14 results
10-K
2023 FY
NMRA
Neumora Therapeutics Inc.
7 Mar 24
Annual report
4:05pm
to permit the import or export of products, or require us to conduct a product recall.
Any government investigation of alleged violations of law could
424B4
NMRA
Neumora Therapeutics Inc.
18 Sep 23
Prospectus supplement with pricing info
4:12pm
to permit the import or export of products, or require us to conduct a product recall.
Any government investigation of alleged violations of law could
S-1/A
NMRA
Neumora Therapeutics Inc.
11 Sep 23
IPO registration (amended)
6:07am
products, refuse to permit the import or export of products, or require us to conduct a product recall.
Any government investigation of alleged
S-1
NMRA
Neumora Therapeutics Inc.
25 Aug 23
IPO registration
5:03pm
a product recall.
Any government investigation of alleged violations of law could require us to expend significant time and resources in response
S-1
EX-2.1
i5bet3t0 zisc
25 Aug 23
IPO registration
5:03pm
DRS/A
tpw0t4f rwcv
9 Aug 23
Draft registration statement (amended)
12:00am
DRS/A
pai7 p4np1
30 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
vdsj1yuh
2 May 23
Draft registration statement (amended)
12:00am
DRS/A
q77q uwoqw4t09
2 Sep 22
Draft registration statement (amended)
12:00am
DRS/A
uu60ft62 55
10 Jun 22
Draft registration statement (amended)
12:00am
DRS/A
hqmxdz
2 May 22
Draft registration statement (amended)
12:00am
DRS/A
f4qcjv0jl3b
23 Dec 21
Draft registration statement (amended)
12:00am
DRS
i663 5hlgw
8 Nov 21
Draft registration statement
12:00am
- Prev
- 1
- Next